Search

Your search keyword '"CA 125 test"' showing total 823 results

Search Constraints

Start Over You searched for: Descriptor "CA 125 test" Remove constraint Descriptor: "CA 125 test"
823 results on '"CA 125 test"'

Search Results

1. The inflammatory markers combined with CAI 25 may predict postoperative survival in endometrial cancer.

2. Estimating sojourn time and sensitivity of screening for ovarian cancer using a Bayesian framework.

3. Efficacy of total laparoscopic hysterectomy without uterine manipulators in patient with early-stage cervical cancer.

4. Prospective external validation of IOTA methods for classifying adnexal masses and retrospective assessment of two‐step strategy using benign descriptors and ADNEX model: Portuguese multicenter study.

5. Prediction of postoperative residual primary ovarian neoplasm or metastatic lesion close to rectum of serous ovarian carcinoma based on clinical and MR T1-DEI features.

6. A Case of Eosinophilic Cholecystitis with Polyserositis Mimicking Malignancy.

7. Relationship between human epididymal protein 4 and depth of tumor invasion, postoperative recurrence, and metastasis of epithelial epithelial ovarian cancer.

8. Carbohydrate antigen 125 on epicardial fat and its association with local inflammation and fibrosis-related markers.

9. Association of allostatic load with overall survival in epithelial ovarian cancer.

10. Clinical Trial Protocol for ROSELLA: a phase 3 study of relacorilant in combination with nab-paclitaxel versus nab-paclitaxel monotherapy in advanced platinum-resistant ovarian cancer.

11. Procalcitonin and C‐reactive protein as early markers of anastomotic leakage in intestinal resections for advanced ovarian cancer (EDMOCS).

12. Osteopontin, death and cardiovascular events in stage G3–4 CKD patients: a joint model analysis.

13. Clinical value of serum tumor markers in assessing the efficacy of neoadjuvant chemotherapy in advanced ovarian cancer: single-center prospective clinical study.

14. Comparison of Laparoscopic Surgery and Expectant Management in Patients with Adnexal Masses During Pregnancy in A High-Volume Tertiary Center.

15. The potential value of cancer‐testis antigens in ovarian cancer: Prognostic markers and targets for immunotherapy.

16. Analysis of factors affecting pregnancy rate after laparoscopic surgery for infertility associated with endometriosis.

17. Disparities of tumour markers in intraperitoneal drainage fluid between laparoscopic and open radical gastrectomy for gastric cancer.

18. Surgical treatment for pulmonary metastasis from ovarian cancer: a retrospective case series.

19. CA-125 elimination rate constant K (KELIM) as a promising predictor of complete cytoreduction after neoadjuvant chemotherapy in advanced ovarian cancer patients: a retrospective study from two Chinese hospitals.

20. Efficacy of fertility-sparing treatment with LNG-IUS is associated with different ProMisE subtypes of endometrial carcinoma or atypical endometrial hyperplasia.

21. Randomized Phase II Study of Gemcitabine With or Without ATR Inhibitor Berzosertib in Platinum-Resistant Ovarian Cancer: Final Overall Survival and Biomarker Analyses.

22. Randomized phase 2 trial of tremelimumab and durvalumab in combination versus sequentially in recurrent platinum‐resistant ovarian cancer.

23. Human tumour vessel heterogeneity in ovarian cancer and its association with response to neoadjuvant chemotherapy.

24. Construction and validation of log odds of positive lymph nodes (LODDS)-based nomograms for predicting overall survival and cancer-specific survival in ovarian clear cell carcinoma patients.

25. Acute abdominal pain from ovarian endometriosis.

26. The impact of varying levels of residual disease following cytoreductive surgery on survival outcomes in patients with ovarian cancer: a meta-analysis.

27. 5-Hydroxymethylcytosine signals in serum are a predictor of chemoresistance in high-grade serous ovarian cancer.

28. Study of neoadjuvant chemotherapy in advanced malignant ovarian germ cell tumors at a tertiary center in western India.

29. The role of EUS-guided iodine-125 seed implantation in patients with unresectable ampullary cancer after relief of obstructive jaundice.

30. Are preoperative serum cancer antigen 125 levels a prognostic factor for outcome in epithelial ovarian cancer? A systematic review.

31. Preoperative Myosteatosis and Prognostic Nutritional Index Predict Survival in Older Patients With Resected Biliary Tract Cancer.

32. Prognostic value of HE4 in advanced-stage, high-grade serous ovarian cancer: Analysis of HE4 kinetics during NACT, predicting surgical outcome and recurrence in comparison to CA125.

33. Preoperative and pre-chemotherapy CA-125 levels in high-risk early-stage ovarian cancer – An NRG/GOG study.

34. The role of adenocarcinoma subtypes and immunohistochemistry in predicting lymph node metastasis in early invasive lung adenocarcinoma.

35. Maintenance Chemotherapy in Patients with Platinum-Sensitive Relapsed Epithelial Ovarian Cancer after Second-Line Chemotherapy.

36. Efficacy and safety of VEGF/VEGFR inhibitors for platinum-resistant ovarian cancer: a systematic review and meta-analysis of randomized controlled trials.

37. Diagnostic Value of MRI Compared to Histopathological Results in Differentiating Benign from Malignant Ovarian Masses.

38. CAR-T cell immunotherapy for ovarian cancer: hushing the silent killer.

39. Randomized, two‐arm, noncomparative phase 2 study of olaparib plus cediranib or durvalumab in HRR‐mutated, platinum‐resistant ovarian cancer: A substudy of KGOG 3045.

40. Evaluation of new biomarkers in stage III and IV endometriosis.

41. Pancreatic index: A prognostic factor of upfront surgery for body or tail pancreatic ductal adenocarcinoma with vascular involvement—A retrospective study.

42. A nomogram was developed using clinicopathological features to predict postoperative liver metastasis in patients with colorectal cancer.

43. PEGylated Fluorescent Anti-carcinoembryonic Antigen Antibody Labels Colorectal Cancer Tumors in Orthotopic Mouse Models.

44. Serum and follicular fluid metabolome and markers of ovarian stimulation.

45. Clinical efficacy analysis of radioactive 125I particle implantation for the treatment of pelvic local recurrence of cervical cancer after radiotherapy.

46. Comparison of the diagnostic accuracy of HE4 with CA125 and validation of the ROMA index in differentiating malignant and benign epithelial ovarian tumours among patients in Lagos, Nigeria.

47. Survival outcomes of epithelial ovarian cancer treated at a tertiary-level hospital in India.

48. Subjective assessment and IOTA ADNEX model in evaluation of adnexal masses in patients with history of breast cancer.

49. Predictive value of serum YKL-40, interleukin-37, and cancer antigen 125 panel in noninvasive staging of endometriosis.

50. Prognostic role of CA‐125 in patients undergoing transcatheter aortic valve replacement: A systematic review and meta‐analysis.

Catalog

Books, media, physical & digital resources